NCT03987347

Brief Summary

This study evaluates the health condition and its evolution with time of Cannabis consumers in the Canadian population.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 17, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

Same day

First QC Date

June 13, 2019

Last Update Submit

December 15, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Neurocognitive disorder

    The decrease of cognitive function changes the activities of daily living to older adults. Instrumental Activities of Daily Living Scale ( IADLs) will be used to assess independent living skills to people who are a diagnosis of mild cognitive impairment. A summary score range from 0 ( low function, dependent) to 8 ( high function, independent) will be given to each participant based on their daily activities.

    around 20 years

Secondary Outcomes (1)

  • Depression

    around 20 years

Interventions

People who are enrolled in the Canadian Longitudinal Study on Aging. Participants undergo repeated waves of the same standardized data collection every three years. All participants are also contacted by telephone 18 months after baseline assessment to complete the Maintaining Contact Questionnaire.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People from Canada who were enrolled in the Canadian Longitudinal Study on Aging the last 20 years, and who have consumed different cannabis products for different reasons either recreational or medical.

You may qualify if:

  • Living in Canada the last 20 years
  • Being 60 years and over
  • Being consumer of cannabis

You may not qualify if:

  • Living outside Canada the last 20 years
  • Have never consumed cannabis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Interventions

Watchful Waiting

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Olivier Beauchet, MD

    Jewish General Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Professor of Geriatrics

Study Record Dates

First Submitted

June 13, 2019

First Posted

June 17, 2019

Study Start

December 1, 2020

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

December 17, 2020

Record last verified: 2020-12

Locations